In recent guidelines [21], Katznelson et al recommended measuring insulin-like growth factor 1 (IGF-1) in patients who have several of these associated conditions: sleep apnea syndrome, type 2 diabetes mellitus, debilitating arthritis, carpal tunnel syndrome, hyperhidrosis, and hypertension. The gene discussed is IGF1; the disease is hypertensive disorder.